The Kaplan–Meier analysis showed that high ERα expression (> 40% immunoreactive tumor cells) in GBM patients was associated with significantly longer survival (Log rank: p = 0.0111, Fig. 3a), compared to low expression of ERα. This evidence concerns the gene ESR1 and glioblastoma.